• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.97% Nasdaq Up1.89%

    FluoroPharma Medical, Inc. (FPMI)

    -Other OTC
    0.47 Up 0.01(1.09%) 3:17PM EST
    Add to Portfolio
    ProfileGet Profile for:
    FluoroPharma Medical, Inc.
    8 Hillside Avenue
    Suite 207
    Montclair, NJ 07042
    United States - Map
    Phone: 973-744-1565
    Website: http://www.fluoropharma.com

    Index Membership:N/A
    Full Time Employees:5

    Business Summary 

    FluoroPharma Medical, Inc., a biopharmaceutical company, is engaged in the discovery, development, and commercialization of molecular imaging pharmaceuticals with primary applications in the area of cardiology. The company’s product portfolio includes BFPET, an imaging agent that has completed Phase Ia clinical trial in stress-testing for patients with presumptive or proven cardiac artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase II clinical trials to assess myocardial metabolism for patients with coronary artery disease. It is also involved in developing VasoPET, a molecular imaging agent for the detection of ‘vulnerable’ coronary artery plaque in patients with CAD. The company has license agreement with Massachusetts General Hospital. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on FluoroPharma Medical, Inc.

    Key Executives 
    Mr. Johan M. Spoor , 42
    Chairman, Chief Exec. Officer and Pres
    Ms. Tamara Rhein , 42
    Chief Financial Officer and Principal Accounting Officer
    Dr. Boyan Goumnerov M.D., 55
    Chief Operating Officer and VP Clinical Operations
    Mr. Edward L. Lyons Jr.,
    VP of Marketing
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders